Featuring a variety of sessions for each track, the Genitourinary Cancers Symposium will focus on prevention, screening, diagnosis, multidisciplinary treatment, translational research, and current controversies in the field. The program will include case-based panel discussions where Symposium attendees will play an active role in the conversation by using audience-response technology. All educational sessions will engage attendees through the use of eQ&A, in which questions may be sent via website submission. Back by popular demand, the program will also feature Best of Journals Sessions for both prostate and renal cell cancers, featuring some of the most thought-provoking and relevant journal articles published within the past year. All program tracks will include a Year in Review Lecture or a Keynote Lecture which will highlight the most up-to-date science and clinical practice for each disease site.
New for 2017, attendees need their username and password to access the CE Portal. If you do not know your username or password, you may use your email address to retrieve them. If you do not know the email address associated with your account, please contact
- Onsite: ASCO staff at the Tech Help Desk in the Posters, Exhibits, and Food Service Room or at the Registration and Customer Service Desk.
- Off-site: ASCO Customer Service from 8:30 AM - 5:00 PM (ET) at firstname.lastname@example.org, 888-282-2552 or 703-299-0158.
Accreditation and Designation Statement
In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physician
The American Society of Clinical Oncology designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other attendees may request a Certificate of Participation after submitting their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
Educational Needs Statement
The 2017 Genitourinary (GU) Cancers Symposium offers a distinct opportunity for clinicians across disciplines and professions to keep pace with updates in therapies and new drugs, building competence in the evaluation and integration of new screening, diagnostic and treatment options into the standard of care for patients with GU cancers. Emerging science is identifying new targets for drug development, creating new avenues for treatment based on our growing awareness of the immune mechanisms of disease. In the 2016 Genitourinary Cancers Symposium impact evaluation report, learner feedback also noted existing knowledge and practice gaps in the use of novel diagnostic approaches, and particularly genomic information, in clinical decision making. Lastly, the ASCO Value Framework now provides further guidance to compare cost and efficacy when multiple treatment options are appropriate.
This Symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of genitourinary cancers, including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.
Learning Objectives and Competencies
Upon participation in this activity, attendees will be able to
- Assess how advances in active surveillance could improve treatment options for patients with prostate cancer;
- Explore the use of liquid biopsy and molecular testing to more accurately assess the tumor microenvironment in patients with prostate cancer;
- Examine how to optimize multidisciplinary treatment options, including surgery, radiation therapy, and immunotherapy, to improve overall outcomes in patients with muscle invasive and metastatic bladder cancers;
- Identify strategies to address the research and clinical challenges unique to patients with non-muscle invasive bladder cancer;
- Describe each role within the multidisciplinary care team in treating patients with penile and urethral cancers, including approaches to improve coordination among team members;
- Evaluate the risks and benefits of treatment intensification for patients with advanced testicular cancer; and
- Discuss how the identification of novel targets and markers could potentially impact the diagnosis and treatment options for patients with renal cancer.
This activity was planned in the context of the following attributes
|Institute of Medicine (IOM) Competencies||Accreditation Council for Graduate Medical Education (ACGME) Core Competencies|
Disclaimer and Unlabeled Usage Statement
The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the symposium cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters. Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.
Attendees can log in to the iPlanner or CE Portal to access any of the following certificates after noting their participation:
- Continuing Medical Education Certificate – available for physicians who would like to receive CME credits for their participation at the Symposium
- Certificate of Participation – all other attendees may request a Certificate of Participation after recording their session participation. Please note that all final decisions regarding certificate acceptance toward any licensure requirements will be made by the licensing organization to which the certificate is submitted.
- Certificate of Attendance – Attendees can download a Certificate of Attendance from the Attendee Resource Center if they need a record of their attendance at the Symposium but do not require documentation for continuing education purposes. Please note that this certificate does not award any continuing education credits.
For instructions on how to claim credit and access certificates, please see the ‘Symposium Feedback and Credit Claim Instructions’ section.
Symposium Feedback and Credit Claim Instructions
Every participant is encouraged to submit a Symposium Feedback Form, provide session ratings, and access certificates for the Symposium through the iPlanner app. Your feedback is utilized by leadership to enhance programs, develop new initiatives, gauge educational impact, and plan for future meetings.
- To provide feedback on a specific session
- Download the iPlanner app
- Select a session by searching by time or track
- Select “Rate This Session” to submit feedback on each session you attend
- To access certificates and claim credit
- Log into the CE Portal using your ASCO.org username and password
- Select a session by searching by time or keyword
- Select “Claim More Credits” to claim CME credits and access your certificate
- To give overall feedback on the meeting
- Submit a Symposium Feedback Form
To receive ABIM MOC points, participants must submit their Symposium Feedback Form, available on the iPlanner and CE Portal, and claim their CME credits for the Symposium by March 20, 2017. Once both of these steps are complete, ASCO will transmit all information to ABIM on the participant’s behalf.